A proposal to allow terminally ill people access to drugs that are still completing clinical trials is advancing in Colorado.
A House committee voted 10-1 Tuesday for a bill to expand access to drugs that have not yet been approved by the Federal Drug Administration.
Similar proposals are pending in several states.
The so-called "Right To Try" legislation still requires doctors to sign off on the use of an investigational product.
The bill has been heavily amended to clarify that patients and not health insurers or hospitals will have to pay for the care.